FTW24: Creating Strength in Numbers for Pharma & Biotech Arena
In an industry dominated by consolidation and large distributors, FTW24 is creating a third path for small-but-mighty businesses in the pharma and biotech arena. We bring independent owners together, creating collective strength that delivers better outcomes for everyone involved. Our approach offers flexibility while our founder-led approach ensures we truly understand the challenges you face.
Why We Exist
Industry Consolidation
The pharmaceutical and biotechnology supply chain is experiencing unprecedented consolidation. Major distributors are expanding their market share through aggressive acquisition strategies, creating an increasingly challenging environment for smaller independent businesses.
Limited Options
Small independents typically face two unappealing choices: continue struggling against growing competitive pressures with diminishing returns, or sell their business below its true value due to limited negotiating leverage.
Strength in Numbers
FTW24 creates a powerful third option by bringing together complementary businesses under one strategic umbrella, preserving independence while creating collective strength that can compete effectively in today’s market.
The pharma and biotech supply chain is changing fast, with larger distributors growing through consolidation. For smaller independents, this can mean tighter margins, fewer options, and uncertain futures.
FTW24 offers a different path. We bring specialist businesses together, preserving their individuality while building the collective strength to thrive in a changing market.
Without sufficient scale, these independents often find themselves in an increasingly precarious position. Many business owners find themselves working harder than ever just to maintain their position, watching margins erode despite delivering excellent products and services. Others feel pressured to sell prematurely, accepting valuations far below what their businesses are truly worth because they lack the scale necessary to attract premium offers.
FTW24 was founded specifically to address this market imbalance. We believe that by creating strength in numbers, small-but-mighty businesses can achieve together what would be impossible individually. Our collaborative approach preserves what makes each business special while creating the collective scale necessary to thrive in today’s consolidated market.
Our Vision
FTW24 is built on the belief that small but mighty businesses in the pharmaceutical and biotechnology supply chain deserve the same opportunities as larger competitors. From high-purity gaskets, tubing, hoses, and single-use components to specialist services and installations, these companies are the backbone of innovation and quality.
Too often, they face disproportionate challenges despite their excellence. FTW24 is changing that by creating a collaborative ecosystem where independent owners keep their unique identities while benefiting from collective scale. Together, we unlock capabilities and opportunities once reserved for much larger players.
Our approach creates immediate benefits through shared resources whilst simultaneously positioning members for stronger future outcomes. By combining complementary businesses, we can create a group substantial enough to attract strategic buyers looking for established platforms in the £20M+ range, a sweet spot that individual businesses might struggle to reach independently.
Knowledge & Expertise
Access collective wisdom, industry insights, and specialised expertise across the entire pharma/biotech supply chain that would be impossible to develop individually.
Enhanced Valuation
Position your business for significantly stronger valuations through operational improvements, strategic alignment, and the premium that comes with scale.
Strategic Attraction
Become part of a collective large enough to attract serious attention from strategic buyers seeking established platforms in the £20M+ range.
This vision isn’t merely theoretical, it’s grounded in market realities and proven business principles. By working together, FTW24 members create mutual benefits whilst preserving what makes each business special.
The FTW24 Model
We’ve designed our model to be straightforward, flexible, and aligned with the diverse needs of pharma and biotech supply chain business owners. Understanding that owners have different goals, timelines, and comfort levels, our tiered approach ensures there’s a suitable entry point for everyone.
Each tier is designed to build upon the previous one, creating a natural progression as owners become more comfortablewith the model. This flexible approach ensures businesses can engage at the level that makes most sense for their currentsituation, with opportunities to deepen their involvement over time.
Above all, the FTW24 model is pragmatic, owner-friendly, and focused on delivering tangible benefits at every stage of engagement. Whether you’re looking for community support, exit preparation, or full consolidation, we’ve built a framework that delivers value from day one.
Why Us?
FTW24 stands apart because it’s built on lived experience rather than theoretical models. Our approach is grounded in the real-world challenges and opportunities specific to the pharma and biotech supply chain sector.
We’ve walked in your shoes. We understand the unique pressures of running a small business in a sector dominated by giants, and we’ve succeeded despite those challenges.
This firsthand understanding means we create practical solutions that work in the real world, not just on spreadsheets. We know which levers actually move valuations in this sector, which operational improvements deliver the greatest returns, and which strategies genuinely attract strategic buyers.
Founder’s Journey
Murph’s experience as the founder of Pure Transfer Ltd (PTL) provides invaluable insight
into the challenges and opportunities specific to the high- purity supply sector.
PTL successfully competed against much larger competitors by focusing on quality, reliability, and deep customer relationships, the same principles that guide FTW24.
Industry Connections
Our extensive network spansvASME-BPE committees, trustedvsuppliers, global distributors, and key decision-makers throughout the pharma and biotech ecosystem. These relationships provide our members with access to opportunities, insights, and partnerships that would be
ifficult to develop independently.
Proven Results
We have a demonstrated history of building small, independent businesses into respected players capable of competing effectively against industry giants. Our methodology isn’t theoretical4it’s been refined through real-world application in precisely the market conditions our members face.
These credentials make FTW24 uniquely qualified to help small-but-mighty businesses unlock their hidden value. We understand the nuances of this sector because we’ve navigated them successfully ourselves. Our approach combines practical industry knowledge with strategic vision, creating a partnership that delivers immediate benefits while building toward long-term success.
The Endgame
While FTW24 delivers immediate benefits to members, we’re ultimately focused on creating transformative long-term outcomes. Our strategic vision extends beyond mere survival in a consolidating market4we’re building something substantial together.
Self-Sustaining Community
We begin by creating a vibrant community that delivers immediate value through shared resources, collective purchasing, and knowledge exchange. This
foundation pays for itself through tangible cost savings and operational improvements.
Enhanced Valuation Platform
As the community strengthens, we develop a platform that systematically increases business valuations through strategic positioning, operational excellence, and coordinated market approaches that preserve optionality for all
Strategic Exit Opportunity
The culmination is a consolidated group with the scale, capabilities, and market position to attract premium offers from strategic buyers seeking established platforms in the £20M+ range, creating outcomes that would be unachievable individually.
This journey4from small-but-mighty independents to a consolidated £20M+ platform positioned for optimal exit, represents the core promise of FTW24. We create a path that preserves what makes each business special while unlocking the significant benefits that come with scale.
For business owners, this means the ability to:
- Maintain operational control while reducing administrative burden
- Access growth opportunities previously beyond reach
- Build genuine enterprise value rather than just creating a job
- Position for a significantly enhanced exit when the time is right
- Create legacy and continuity for employees and customers
FTW24 is fundamentally about creating better options for pharma and biotech supply chain business owners. By combining our strengths, we can achieve together what would be impossible alone4creating a win for owners, employees, customers, and the industry as a whole.
Join us in building something extraordinary.